Clinical Trial Update: Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing N-acetylcysteine for improving learning and motor behavior in children with Neurofibromatosis type 1 has completed and posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Neurofibromatosis 1 | Phase 2 | Status: COMPLETED | Results posted: 2022-03-15